On treatment prediction of post-treatment sustained response to Peginterferon alfa-2a for HBeAg-negative Chronic Hepatitis B (CHB) patients using HBsAg and HBV DNA levels at weeks 12 and 24: PERSEAS cohort final results

Autor

Goulis, I.; Karatapanis, S.; Akriviadis, E. A.; Deutsch, M.; Dalekos, G. N.; Raptopoulou-Gigi, M.; Mimidis, K.; Germanidis, G.; Triantos, C. K.; Drakoulis, C.; Chounta, A.; Vafiadis, I.; Hatzis, G.; Gagalis, A.; Vlachogiannakos, J.; Zintzaras, E.; Koulouris, S.; Bakalos, G.; Papatheodoridis, G. V.

Fecha

2013

Materia

Gastroenterology & Hepatology

Mostrar el registro completo del ítem

URI

http://hdl.handle.net/11615/28108

Colecciones

• Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]